Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by Caritas3on Jul 25, 2017 3:28pm
112 Views
Post# 26507565

RE:If you want to see into the future

RE:If you want to see into the future Alan...You sure are sour pessimist! ADK and VRS are two totally different companies. For example, you say VRS even had the POTENTIAL for a lucrative contract in Mexico. So they didn't get it. Now reflect for a moment on the fact that ADK recently announced a contract with Mexico for over $5,000,000! Do you appreciate the difference? Plus it seems based on information coming from the AGM presentation that ADK expects to continue to achieve its business plan. Among other very positve developments more contracts are expected in the near term and beyond. Additionally, it sounds like the company is getting very close to a commercially viable AI for assessing cardiac risk for individuals. We shall see how ADK developments unfold during the course of the year and beyond. In the meantime, some investors after having done considerable DD believe the company has a very bright future!
Bullboard Posts